Methylation of several tumor-related genes, including MINT17, MINT31, TFPI2, WIF1, RASSF1A, and SOCS1, comprising the first melanoma CIMP, increased significantly with advanced clinical stages, suggesting that their inactivation is associated with tumor progression. Here, RASSF1 is linked to melanoma.